top of page

ONE TEST FOR ALL

GT. Check-Up™  ''$999''

mae.gif

GENETIC TRAINER® INTRODUCING THE WORLD'S

MOST ADVANCED DNA TEST!

GT. Check-Up based on molecular DNA analysis of 120 gene regions. 

GT. Check-Up determines sports performance and the risks of 37 genetic diseases, ranging from cancer to Alzheimer's, to obesity, and diabetes.

GENETIC PREDISPOSITIONS

1) Breast Cancer (BC)

2) Lung Cancer (LC)

3) Colorectal Cancer (CC)

4) Gastric Cancer (GC)

5) Basal Cell Carcinoma (BCC)

6) Bladder Cancer

7) Prostate Cancer (PC)

8) Melanoma

9) Atrial fibrillation (AF)

10) Coronary artery disease (CAD)

11) Intracranial aneurysm (IA)

12) Peripheral arterial disease (PAD)

13) Venous thromboembolism (VTE)

14) Obesity

15) Type 1 diabetes

16) Type 2 diabetes

17) High blood pressure

18) Hyperthyroidism

19) Folate Metabolism

20) Gluten Intolerance

21)  Lactose Intolerance

22) Sugar Consumption

23) Alzheimer

24) Osteoporosis

25) Multiple Sclerosis (MS),

26) Migraine with Aura

27) Psoriasis

28) Rheumatoid arthritis

29) The systemic lupus erythematosus (SLE)

30) Primary open-angle glaucoma (POAG)

31)  Exfoliating glaucoma

32) Age-related macula degeneration (AMD)

33) Vitamine B12 

34) Vitamine B6

35) Vitamine D

36) ACTN'3 (R577X)

37) ACE (I/D) 

list of analyzed genes

 

 

REPORTING

 

 ●Determining the most common 40 genetic disease risks in the world in numerical rates.

 

●Comparing personal risks with population risks numerically.

 

●Separate disclosure of the measures required to reduce the genetic and environmental risk rates for each disease.

 

●Explanation of the trigger factors one by one according to the risk rate for each disease.

 

●Descriptive information of all environmental factors necessary to minimize or even eliminate risks by risk rate for each disease.

 

●Nutritional and exercise recommendations for each disease.

 

●Emergency response warning against high-risk rates.

 

●Assessing the possibility of increased risk after the interaction of other genetic regions despite the low risk of disease.

 

●Assessing the possibility of decreasing the risk after the interaction of other genetic regions despite the high risk of disease.

bottom of page